Novo Nordisk A/S: Novo Nordisk files annual report with the SEC

Novo Nordisk A/S: Novo Nordisk files annual report with the SEC 
BAGSVAERD, DENMARK -- (Marketwire) -- 02/07/13 --  Novo Nordisk A/S
has filed its Annual Report 2012 on Form 20-F for the financial year
2012 with the US Securities and
Exchange Commission (SEC),
incorporating by reference parts of the Novo Nordisk
A/S Annual
Report 2012. The reports are available at the SEC's website, as well as on 
Shareholders and ADR holders may receive a hard copy of the annual
reports free
of charge upon request by filling out a request form on or upon
request to either Tel: (+1) 609 786 4575 or
by e-mail to
When e-mailing, please state the
exact mailing address and the document(s) you
wish to receive. 
Read the full release in PDF format: 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: Novo Nordisk A/S via Thomson Reuters ONE 
Further information: 
Anne Margrethe Hauge
+45 4442 3450 
Kasper Roseeuw Poulsen
+45 4442 4303 
Frank Daniel Mersebach
+45 4442 0604 
Lars Borup Jacobsen
+45 3075 3479 
Jannick Lindegaard (US)
+1 609 786 4575
Press spacebar to pause and continue. Press esc to stop.